Daniel W. Lin, MD, reviews new guidance on using MRI, biomarkers, and more, to improve the detection of prostate cancer.

Black men choose aggressive prostate cancer treatment—regardless of anticipated life expectancy—more often than Hispanic or Caucasian men, according to new research by Cedars-Sinai investigators ...

New research in JNCCN—Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate cancer later in life, and treated according to NCCN ...

Prostate cancer screening would save thousands of lives, a landmark study has revealed. A national programme would save one life for every 500 men tested, according to the most comprehensive analysis ...

Risk of death and cause of death 30 years after diagnosis as a proportion of 100 men. Grey figures indicate the proportion of men alive after 30 years, blue figures the proportion of men who died of ...

Early findings show efficacy of water vapor therapy for treating intermediate-risk prostate cancer with minimal procedural ...

Patients with nonmetastatic prostate cancer are more likely to die from other causes than from cancer when treated per guidelines. The 15-year cancer mortality risk is 5.5% for low-risk and 22% for ...

Sir Chris Hoy has recently shared a number of health updates as he continues his fight against stage four cancer. The Olympic legend's world was turned upside down three years ago when he was ...